122 related articles for article (PubMed ID: 38573778)
1. Engineering Nanozymes for Tumor Therapy via Ferroptosis Self-Amplification.
Liu S; Wei Y; Liang Y; Du P; Lei P; Yu D; Zhang H
Adv Healthc Mater; 2024 Apr; ():e2400307. PubMed ID: 38573778
[TBL] [Abstract][Full Text] [Related]
2. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
[TBL] [Abstract][Full Text] [Related]
3. Amorphous NiB@IrO
Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
[TBL] [Abstract][Full Text] [Related]
4. High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Meng X; Li D; Chen L; He H; Wang Q; Hong C; He J; Gao X; Yang Y; Jiang B; Nie G; Yan X; Gao L; Fan K
ACS Nano; 2021 Mar; 15(3):5735-5751. PubMed ID: 33705663
[TBL] [Abstract][Full Text] [Related]
5. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
6. Dual enzyme-like Co-FeSe
Zhang J; Ha E; Li D; He S; Wang L; Kuang S; Hu J
J Mater Chem B; 2023 May; 11(19):4274-4286. PubMed ID: 37140154
[TBL] [Abstract][Full Text] [Related]
7. NADPH Oxidase-Like Nanozyme for High-Efficiency Tumor Therapy Through Increasing Glutathione Consumption and Blocking Glutathione Regeneration.
Han D; Ding B; Zheng P; Yuan M; Bian Y; Chen H; Wang M; Chang M; Kheraif AAA; Ma P; Lin J
Adv Healthc Mater; 2024 Apr; 13(11):e2303309. PubMed ID: 38214472
[TBL] [Abstract][Full Text] [Related]
8. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy
Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X
Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601
[No Abstract] [Full Text] [Related]
10. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
11. Single-Atom Pd Nanozyme for Ferroptosis-Boosted Mild-Temperature Photothermal Therapy.
Chang M; Hou Z; Wang M; Yang C; Wang R; Li F; Liu D; Peng T; Li C; Lin J
Angew Chem Int Ed Engl; 2021 Jun; 60(23):12971-12979. PubMed ID: 33772996
[TBL] [Abstract][Full Text] [Related]
12. Reactive Oxygen Species Amplifier for Apoptosis-Ferroptosis Mediated High-Efficiency Radiosensitization of Tumors.
Wang Z; Ren X; Li Y; Qiu L; Wang D; Liu A; Liang H; Li L; Yang B; Whittaker AK; Liu Z; Jin S; Lin Q; Wang T
ACS Nano; 2024 Apr; 18(14):10288-10301. PubMed ID: 38556985
[TBL] [Abstract][Full Text] [Related]
13. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
14. Multi-enzyme Co-expressed Dual-Atom Nanozymes Induce Cascade Immunogenic Ferroptosis via Activating Interferon-γ and Targeting Arachidonic Acid Metabolism.
Liu Y; Niu R; Deng R; Song S; Wang Y; Zhang H
J Am Chem Soc; 2023 Apr; 145(16):8965-8978. PubMed ID: 37058189
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
16. Defect engineering to tailor structure-activity relationship in biodegradable nanozymes for tumor therapy by dual-channel death strategies.
Su Y; Lv M; Huang Z; An N; Chen Y; Wang H; Li Z; Wu S; Ye F; Shen J; Li A
J Control Release; 2024 Mar; 367():557-571. PubMed ID: 38301929
[TBL] [Abstract][Full Text] [Related]
17. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
[TBL] [Abstract][Full Text] [Related]
18. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
20. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
